Baxter International rises on upbeat forecast, strong Q4

Baxter International

20/02/2025 13:24

** Shares of medical device maker Baxter International
 BAX.N  rise 7.9% to $33.25 in premarket trading
    ** Co beats expectations for Q4 earnings and forecasts a
largely better-than-expected 2025 adjusted profit, helped by
strong sales of its medical devices 
    ** Posts Q4 revenue at $2.75 billion, beating estimates of
$2.67 billion according to data compiled by LSEG
    ** Co earned 58 cents per share in Q4, compared with
estimates of 52 cents
     ** Expects 2025 adjusted profit to be between $2.45 and
$2.55 per share, banking on strong sales of its medical devices,
the midpoint of which is above analyst's estimate of $2.47 per
share
    ** BAX has fallen ~25% in the last 12 months as it dealt
with hurricane-related disruptions at its North Carolina
facility 

 (Reporting by Siddhi Mahatole)
 ((Siddhiprabhanjan.mahatole@thomsonreuters.com))